About Sudhishubha
It operates as a B2B. Sudhishubha offers products and services including Speciality Chemicals, Custom Synthesis, Process Development, Peptide Synthesis, and Research Chemicals.
- SectorsHealthcareChemicals & Materials
- Email••••••••
- Website sudhishubha.com
- Social LinkedIn Facebook Instagram
- Legal Name Sudhishubha Chemsynthons Llp
- Date of Incorporation 08 Feb, 2022
- Jurisdiction Banhatti, Karnataka, India
Associated legal entities of Sudhishubha
Sudhishubha operates through Sudhishubha Chemsynthons Llp (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Sudhishubha Chemsynthons Llp CIN ABA-5503 | Active | 08 Feb 2022 | Banhatti, Karnataka | – | – | 2 | View details |
Products & Services of Sudhishubha
Sudhishubha offers a comprehensive portfolio of products and services, including Speciality Chemicals, Custom Synthesis, Process Development, Peptide Synthesis, and Research Chemicals.
Supply of chemicals for pharmacy and biotech applications.
Synthesis of products with specified purity and scale.
Development of cost-effective and eco-friendly processes.
Synthesis of peptides using solution and solid phase methods.
Provision of reagents and building blocks for research.
Board of directors of Sudhishubha Chemsynthons Llp (Sudhishubha)
Sudhishubha Chemsynthons Llp is the primary company behind Sudhishubha. The board of Sudhishubha Chemsynthons Llp currently have 2 directors; the longest-serving is Gururaj Mahadev Shivashimpi, appointed in 2022.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Gururaj Mahadev Shivashimpi DIN 09497285 | Designated Partner | 08 Feb 2022 | 4 yrs 8 mo | Sudhishubha Chemsynthons Llp |
| Shubratmani Shivashimpi DIN 09497286 | Designated Partner | 08 Feb 2022 | 4 yrs 8 mo | Sudhishubha Chemsynthons Llp |
Similar companies to Sudhishubha
10 companies that operate in the same segment as Sudhishubha (Immunology & Cancer Therapeutics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment. | 2008 | Ghent, East Flanders, Belgium | USD 61.9 M | USD 1.41 B | 355 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | – | – | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Targeted therapies for cancer treatment are developed. | 2005 | Waltham, Massachusetts, United States | USD 198.29 M | USD 172.35 M | 270 | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Plasma-based biologics are developed for immune deficiency and infectious diseases. | 2005 | Ramsey, Minnesota, United States | USD 17.55 M | USD 510.17 M | 685 | |
Antibody drugs for cancer treatment are developed. | 2015 | Singapore, Singapore | USD 150 M | – | – | |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | 2003 | United States | USD 171.85 M | USD 102.48 M | 338 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Sudhishubha
SudhiShubha ChemSynthons is a research-based chemical company based in Bangalore, India, specializing in supplying specialty chemicals, intermediates, reagents, and research chemicals to pharmacy, biotech, and material science industries. They offer custom synthesis, process development, and peptide synthesis services, focusing on quality, innovation, and eco-friendly processes to meet customer needs in global markets.
Sudhishubha offers Speciality Chemicals, Custom Synthesis, Process Development, Peptide Synthesis, and Research Chemicals.
Sudhishubha operates through Sudhishubha Chemsynthons Llp.
The legal entities of Sudhishubha currently have 2 directors, including Gururaj Mahadev Shivashimpi, Shubratmani Shivashimpi.